Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Noe

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Monitoring and Computing|November 7, 2016
Applicability of stroke volume variation in patients of a general intensive care unit: a longitudinal observational studySebastian Mair, Julia Tschirdewahn, Simon Götz, et al.
Antiviral Therapy|September 3, 2016
Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort resultsCelia Oldenbuettel, Eva Wolf, Ayla Ritter, et al.
Infection|July 23, 2024
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with menLaura Wagner, Christoph Boesecke, Axel Baumgarten, et al.
Antiviral Therapy|August 24, 2022
The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 studyElena Alvarez, Lucy Campbell, Willard Tinago, et al.
AIDS (London, England)|January 20, 2026
Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1Christoph Wyen, Celia Jonsson-Oldenbüttel, Sebastian Noe, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
HIV Medicine|October 7, 2025
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysisGundolf Schuettfort, Jan Borch, Alfonso Cabello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2023
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority StudyEdgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
Infection|November 7, 2025
Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in GermanyFauzi Elamouri, Thomas Lutz, Gabi Knecht, et al.
HIV Medicine|September 5, 2022
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in GermanyChristian Hoffmann, Heiko Jessen, Christoph Wyen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Monitoring and Computing|November 7, 2016
Applicability of stroke volume variation in patients of a general intensive care unit: a longitudinal observational studySebastian Mair, Julia Tschirdewahn, Simon Götz, et al.
Antiviral Therapy|September 3, 2016
Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort resultsCelia Oldenbuettel, Eva Wolf, Ayla Ritter, et al.
Infection|July 23, 2024
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with menLaura Wagner, Christoph Boesecke, Axel Baumgarten, et al.
Antiviral Therapy|August 24, 2022
The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 studyElena Alvarez, Lucy Campbell, Willard Tinago, et al.
AIDS (London, England)|January 20, 2026
Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1Christoph Wyen, Celia Jonsson-Oldenbüttel, Sebastian Noe, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
HIV Medicine|October 7, 2025
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysisGundolf Schuettfort, Jan Borch, Alfonso Cabello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2023
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority StudyEdgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
Infection|November 7, 2025
Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in GermanyFauzi Elamouri, Thomas Lutz, Gabi Knecht, et al.
HIV Medicine|September 5, 2022
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in GermanyChristian Hoffmann, Heiko Jessen, Christoph Wyen, et al.
Pageof 5